Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Details) - Schedule of stock option activity

v3.22.1
Stockholders' Equity (Details) - Schedule of stock option activity - $ / shares
 12 Months Ended
Jan. 30, 2022
Jan. 31, 2021
Feb. 02, 2020
Feb. 03, 2019
Number of options        
Number of options, outstanding, beginning balance (in shares) 495,366 495,366 0  
Number of options, granted (in shares) 0 0 495,366  
Number of options, canceled and forfeited (in shares) 0 0 0  
Number of options, outstanding, ending balance (in shares) 495,366 495,366 495,366 0
Number of options, exercisable at the end of the period (in shares) 0      
Weighted average exercise price        
Weighted average exercise price, outstanding balance (in dollars per share) $ 38.10 $ 38.10 $ 0  
Weighted average exercise price, granted (in dollars per share) 0 0 38.10  
Weighted average exercise price, canceled and forfeited (in dollars per share) 0 0 0  
Weighted average exercise price, outstanding balance (in dollars per share) 38.10 $ 38.10 $ 38.10 $ 0
Weighted average exercise price, exercisable at the end of the period (in dollars per share) $ 0      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]        
Weighted average remaining contractual life, outstanding (in years) 2 years 4 months 6 days 3 years 4 months 6 days 2 years 4 months 2 days 0 years
Average intrinsic value, outstanding, beginning balance (in dollars per share) $ 0 $ 0 $ 0  
Average intrinsic value, outstanding, ending balance (in dollars per share) 28.68 $ 0 $ 0 $ 0
Average intrinsic value, exercisable at the end of the period (in dollars per share) $ 0